| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 63.5 | 60.6 | 31.3 |
| Other income | 0.3 | 1.3 | 0.6 |
| Total income | 63.8 | 61.9 | 31.9 |
| Profit before exceptional items & tax | 0.7 | 1.1 | 1.0 |
| Profit before tax | 0.7 | 1.1 | 1.0 |
| Net profit | 0.4 | 0.9 | 0.8 |
| Operating margin | 1.1% | 1.8% | 3.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -50.00% |
|---|---|
| Net profit, quarter on quarter | -55.60% |
| Revenue, year on year | +102.90% |
| Operating profit, quarter on quarter | +300.00% |
Source
Read the filing ↗
NSE results filing, NSE: AJOONI. Figures extracted from the filing.
Ajooni Biotech Ltd: key numbers
- Share price
- ₹3.19
- Market cap
- ₹54.95 Cr
- Revenue (annual)
- ₹182.4 Cr
- Net profit (annual)
- ₹4.32 Cr
- P/E (TTM)
- 13.9×Sector 29.0×
- Promoter holding
- 26.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajooni Biotech Ltd
All →
12:39 IST
NSE
Financial Results
Ajooni Biotech Q4 FY26 Results: Net Profit ₹0.9 Cr, Down 40.0% YoY
Ajooni Biotech Ltd reported revenue from operations of ₹60.6 Cr (+106.8% YoY) and net profit of ₹0.9 Cr (-40.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.9 Cr · -40.0% YoY